MAPT and Alzheimer disease: At the molecular level, the underlying pathophysiological mechanisms of AD include the extracellular deposition of amyloid-β (Aβ) peptides, known as amyloid plaques, as well as the intracellular development of hyperphosphorylated tau ((Tubulin-Associated Unit) protein aggregates, known as neurofibrillary tangles (NFTs).